Iftihar Koksal. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Antiviral Agents/therapeutic useClinical Trials as TopicDrug Therapy, CombinationGenotypeHepatitis C, Chronic/complicationsHepatitis C, Chronic/drug therapyHepatitis C, Chronic/geneticsHumansInterferon alpha-2Interferon-alpha/therapeutic useKidney Failure, Chronic/complicationsKidney Failure, Chronic/therapyPolyethylene Glycols/therapeutic useRecombinant ProteinsRenal DialysisRibavirin/therapeutic useRisk Factors
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2bpeginterferon alfa-2a
Year: 2006 PMID: 16638088 DOI: 10.1111/j.1440-1746.2006.04285.x
Source DB: PubMed Journal: J Gastroenterol Hepatol ISSN: 0815-9319 Impact factor: 4.029